tirzepatide in type 1 diabetes Adults With Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial @DiabetesCareADA 🔻 −10.3 kg in 12 weeks with tirzepatide vs −0.7 kg with placebo (P<0.0001) 🎯 100% ≥5% Tirzepatide for Medical Weight Loss

We rated the certainty for each comparison and outcome as high, moderate, low, or very low, taking into consideration the risk of bias [26], inconsistency [27], imprecision [28, 29], indirectness [30], and publication bias [31]

Helping reduce muscle fatigue

These insights contribute valuable evidence for the development of scientifically grounded dietary strategies, supporting functional food innovations tailored to plant-based and performance-oriented nutrition

Observational data from patients with type 2 diabetes and concurrent rheumatoid arthritis provide indirect evidence

Similar results were observed in another study, where researchers first injected 6-hydroxydopamine into the medial forebrain bundle of Wistar rats and then performed aVNS treatment

Levocarnitine administration in elderly subjects with rapid muscle fatigue